[TREATMENT OF TOXOPLASMOSIS. (EXPERIMENTAL STUDY)].
D000813:Anilides; D000818:Animals; D000900:Anti-Bacterial Agents; D003091:Colistin; D051379:Mice; D010118:Oxytetracycline; D010404:Penicillin V; D011739:Pyrimethamine; D012106:Research; D012294:Rifamycins; D015572:Spiramycin; D013411:Sulfadiazine; D013754:Tetracyclines; D014123:Toxoplasmosis; D014124:Toxoplasmosis, Animal; D014126:Toxoplasmosis, Ocular
D000813:Anilides; D000900:Anti-Bacterial Agents; D012294:Rifamycins; D013754:Tetracyclines; D013411:Sulfadiazine; C005470:penimepicycline; D015572:Spiramycin; C023808:rifamycin SV; D010118:Oxytetracycline; D011739:Pyrimethamine; D010404:Penicillin V; D003091:Colistin
ANILIDES; ANTIBIOTICS; COLISTIN; EXPERIMENTAL LAB STUDY; MICE; OXYTETRACYCLINE; PENIMEPICYCLINE; PYRIMETHAMINE; RIFOMYCIN; SPIRAMYCIN; SULFADIAZINE; TOXOPLASMOSIS, ANIMAL; TOXOPLASMOSIS, OCULAR
TRAITEMENT DE LA TOXOPLASMOSE. (ETUDE EXP'ERIMENTALE)